🇺🇸 FDA
Patent

US 11746335

Development of dengue virus vaccine components

granted A61KA61K2039/5254A61P

Quick answer

US patent 11746335 (Development of dengue virus vaccine components) held by The Government of the United States of American, as represented by the Secretary, Department of Health and Human Services expires Mon Aug 31 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Government of the United States of American, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Sep 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 31 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K2039/5254, A61P, A61P31/12, A61P31/14